Nature's Script CBD Pain Relief Roll-On Recalled for Subpotent Menthol
FDA Class III recall of Nature's Script CBD Cryotherapy Pain Relief Roll-on (200mg, 1 oz bottles) due to subpotent menthol content less than the labeled 4%. The product did not contain the claimed amount of active ingredient.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The hazard is subpotency (menthol content below label claim), which is a potency and labeling issue rather than a safety hazard. Class III recalls are typically scored 1 or 2.
Plain-English summary
Global Widget LLC is recalling Nature's Script CBD Cryotherapy Pain Relief Roll-on in 1 oz bottles containing 200mg of product, distributed nationwide within the United States. The product's menthol potency was less than the 4% stated on the label.
This is an FDA Class III recall. The subpotent menthol means the product does not deliver the claimed amount of active ingredient for pain relief. Affected lot numbers are 230346 (expiration August 2025) and 230090 (expiration February 2025), with a UPC code of 8-40078-56731-5. Approximately 2466 bottles are affected.
Consumers who have purchased this product should check the lot number and expiration date. Those with affected bottles may contact Global Widget LLC at 8419 Sunstate Street, Tampa, Florida 33634, or contact the FDA's Drug Safety and Availability division for further information about the recall.
The recalled product
- Product
- Nature's Script CBD Cryotherapy Pain Relief Roll on (menthol 4%) 200mg, 1 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634, UPC code: 8-40078-56731-5
- Manufacturer
- GLOBAL WIDGET LLC
- Category
- Drug — Topical Pain Relief
- Hazard
- subpotency
- mislabeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: 230346
- Exp. date Aug 2025
- 230090 Exp. date Feb 2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27